Results 221 to 230 of about 203,270 (263)

Combating cancer immunotherapy resistance: a nano‐medicine perspective

open access: yesCancer Communications, EarlyView.
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong   +10 more
wiley   +1 more source

Phytochemistry, Antibacterial and Antioxidant Activities of Grewia lasiocarpa E. Mey. Ex Harv. Fungal Endophytes: A Computational and Experimental Validation Study

open access: yesChemistry &Biodiversity, EarlyView.
Schematics workflow for the isolation and characterisation of endophytic fungi from grewia lasiocarpa and their biological activity. Abstract The genus Grewia are well‐known for their medicinal properties and are widely used in traditional remedies due to their rich phytochemical composition and potential health benefits.
Nneka Augustina Akwu   +7 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Immunosuppressive Agents

Annual Review of Pharmacology, 1972
Publisher Summary This chapter examines immunosuppressive agents for immunosuppressive effect. It discusses the effect of irradiation on immune response. Irradiation is the least effective of all the immunosuppressive agents used in clinical practice. However, irradiation is used considerably in clinical practice.
A, Gerebtzoff   +2 more
openaire   +4 more sources

New agents for immunosuppression

Best Practice & Research Clinical Gastroenterology, 2021
The human abdomen harbors organs that the host's immune system can attack easily. This immunological storm front leads to diseases like Crohn's Disease, Ulcerative Colitis or Autoimmune Hepatitis. Serious symptoms like pain, diarrhea, fatigue, or malnutrition accompany these diseases.
André Jefremow, Markus F. Neurath
openaire   +2 more sources

Immunosuppressive Agents

Surgical Clinics of North America, 1994
The present success of organ transplantation is largely due to advances in immunosuppressive therapy. Progress has been made from a cytotoxic strategy associated with a high morbidity rate to a strategy that seeks to alter the activity of cells that regulate the immune response, in order to selectively dampen antidonor responses.
B D, Kahan, R, Ghobrial
openaire   +2 more sources

NEW IMMUNOSUPPRESSIVE AGENTS

Gastroenterology Clinics of North America, 1993
In summary, many new modalities of immunosuppression after transplantation are being investigated (Fig. 1). These approaches include various new drugs or monoclonal antibodies that target different cell subsets, cellular activation pathways, cellular effector function or mediators (such as cytokines) of effector function, ligands that stabilize ...
G L, Bumgardner, J P, Roberts
openaire   +2 more sources

Immunosuppressive Agents in Dermatology

Dermatologic Clinics, 1993
Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire   +2 more sources

IMMUNOSUPPRESSIVE AGENTS IN DERMATOLOGY

Dermatologic Clinics, 1998
Azathioprine, cyclophosphamide, methotrexate, and cyclosporine are the immunosuppressive agents most commonly used by dermatologists. Azathioprine has a relatively good safety profile and is therefore often preferred for the treatment of chronic eczematous dermatitides and bullous disorders.
Vincent C. Ho, Jan P. Dutz
openaire   +3 more sources

Immunosuppressive agents for myasthenia gravis

Cochrane Database of Systematic Reviews, 2005
The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear.Assessment of immunosuppressant drug efficacy in MG.We searched the Cochrane Neuromuscular Disease Group Trials Register, MEDLINE (from January 1966 to July 2007), EMBASE (from January 1980 to July 2007), review and trial bibliographies and contacted trial authors.Types
Tarek Sharshar   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy